Lok Sabha Question No. 2595 (UNSTARRED), answered on 2023-08-04
Subject: Funds for Research & Development of New Drugs
Ministry: CHEMICALS AND FERTILIZERS
Asked by: Ramesh Chand Bind

## GOVERNMENT OF INDIA MINISTRY OF CHEMICALS AND FERTILIZERS DEPARTMENT OF PHARMACEUTICALS

LOK SABHA UNSTARRED QUESTION NO. 2595 TO BE ANSWERED ON THE 04 th  August, 2023

Funds for Research & Development of New Drugs

## 2595. SHRI RAMESH CHAND BIND:

Will the Minister of CHEMICALS AND FERTILIZERS be pleased to state:

- (a) the details of the funds allocated for Research and Development of new drugs/vaccines in the country for the last three years, year-wise;
- (b)  whether  the  Government  has  prepared  any  roadmap  for  pharma  industry  to  reduce dependency for raw materials on foreign nations; and (c) if so, the details thereof?

## ANSWER

## MINISTER OF STATE IN THE MINISTRY OF CHEMICALS & FERTILIZERS (SHRI BHAGWANTH KHUBA)

(a):  Research  &  Development  and  innovation  in  the  pharma  sector  is  done  by  number  of institutions and organisations under various Ministries/ Departments, which have their own budgetary provisions.

The  Department  of  Pharmaceuticals  (DoP)  has  set  up  seven  National  Institutes  of Pharmaceutical Education & Research (NIPERs) as institutes of national importance, to nurture and promote quality and excellence in pharmaceutical education and research in India. The allocation for NIPERs over last three years including grants for building and Infrastructure as well as research and academic activities is given in table below.

Council of Scientific and Industrial Research (CSIR) under the Department of Scientific and Industrial Research (DSIR), through its constituent laboratories, has also been pursuing R&D activities for drug discovery and development. Further, Department of Biotechnology (DBT),  along  with  its  Public  Sector  Undertaking  (PSU)  Biotechnology  Industry  Research Assistance  Council  (BIRAC)  has  facilitated  implementation  of  R&D  projects  for  drug discovery in for research and development of new drugs/vaccines.

Allocation during the last three years for these schemes/ programmes are as under:

| Financial year   | NIPERs under DoP*   | CSIR under DSIR   | BIRAC under DBT   |
|------------------|---------------------|-------------------|-------------------|
| 2020-21          | Rs. 333.82 cr.      | Rs. 24.64 cr.     | Rs. 64.52 cr.     |
| 2021-22          | Rs. 372.00 cr.      | Rs. 101.37 cr     | Rs. 62.57 cr.     |
| 2022-23          | Rs. 451.13 cr.      | Rs. 74.79 cr      | Rs. 46.34 cr.     |

Department of Scientific & Technology (DST) has taken steps for development of therapeutic strategies for preventing rare/orphan disorders, for which Rs. 8.56 Cr. has been sanctioned during the current financial year.

(b) & (c): Government has launched Production Linked Incentive (PLI) Scheme for promotion of  domestic  manufacturing  of  critical  Key  Starting  Materials  (KSMs)/  Drug  Intermediates (DIs) and Active Pharmaceutical Ingredients (APIs) in India, with a financial outlay of Rs. 6,940 crores for a tenure from FY 2020-2021 to FY 2029-30. In addition, financial assistance for setting up Common Infrastructure Facilities (CIF) in three Bulk Drugs parks to the tune of Rs. 3,000 cr. for a tenure from FY 2020-21 to 2024-25, with Rs. 1,000 cr for each park, is being provided.

*****